GlassScriptPhysician profile
Taylor Blanco
NPI 1114376746
$2,108.47
in general payments reported to CMS, 2019-2025
12 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $86.45 · 2021: $535 · 2022: $265 · 2023: $387 · 2024: $300 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055 · Entertainment: $56.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.42 |
| Entertainment | $56.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $784.14 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $541.84 | 2021-2025 | Precision7, Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $208.34 | 2022-2025 | Infuse, Biotrue One Day |
| Abb Con-Cise Optical Group LLC | $93.09 | 2020-2023 | Contact Lens, Spectacle Lenses |
| Lkc Technologies, INC. | $91.94 | 2025 | |
| Horizon Therapeutics Plc | $90.61 | 2023 | Tepezza |
| Allergan, INC. | $75.47 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $64.05 | 2022 | |
| Optos, INC. | $56.69 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $49.03 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $36.01 | 2025 | Xdemvy |
| Lombart Brothers, INC. | $17.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.